The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $41.84

Today's change+0.69 +1.68%
Updated December 18 4:02 PM EST. Delayed by at least 15 minutes.
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $41.84

Today's change+0.69 +1.68%
Updated December 18 4:02 PM EST. Delayed by at least 15 minutes.

U.S. Physical Therapy Inc Hits New 20-day High

U.S. Physical Therapy Inc closed up sharply Thursday, rallying (U.S.)$0.69 or 1.68% to (U.S.)$41.84 and setting a new 20-day high. Over the last five days, shares have gained 2.60% and are currently 4.91% off of the 52-week high. Shares have outperformed the S&P 500 by 7.30% during the last year.

Key company metrics

  • Open(U.S.) $41.41
  • Previous close(U.S.) $41.15
  • High(U.S.) $42.00
  • Low(U.S.) $40.97
  • Bid / Ask(U.S.) $37.50 / (U.S.) $0.00
  • YTD % change+18.66%
  • Volume35,907
  • Average volume (10-day)67,191
  • Average volume (1-month)59,505
  • Average volume (3-month)51,416
  • 52-week range(U.S.) $29.56 to (U.S.) $44.00
  • Beta0.89
  • Trailing P/E27.30×
  • P/E 1 year forward24.21×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.48
  • Dividend yield1.15%
  • Trailing EPS(U.S.) $1.53
Updated December 18 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.84%

Based on its net profit margin of 9.84%, U.S. Physical Therapy Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.93%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue78787069
Total other revenue--------
Total revenue78787069
Gross profit19221716
Total cost of revenue59565352
Total operating expense66646059
Selling / general / administrative7877
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income1114109
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax111499
Income after tax7966
Income tax, total4433
Net income5634
Total adjustments to net income--------
Net income before extra. items5634
Minority interest-2-3-3-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5634
Inc. avail. to common incl. extra. items5634
Diluted net income5634
Dilution adjustment--------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.430.520.270.32
Dividends per sharevalue per share0.120.120.120.10
Diluted normalized EPSvalue per share0.420.520.270.33